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ABSTRACT 
A reversed-phase liquid chromatographic method for the separation of 26 phenylthiocarbamyl derivatives of amino acids in human 
plasma in ca. 35 min. is described. The method used a C,, column (150 x 4.6 mm I.D., 3 pm) thermostatted at 41°C and a simple 
multistep linear gradient of two solvents. Solvent A was 0.05 A4 sodium acetate (PH 5.1)-acetonitrile (98:2, v/v), and solvent B was 
water-acetonitrile (40:60, v/v). A simple and successful approach to the optimization of the conditions for the separation of the 26 
amino acid derivatives was realized. In the initial phase of development, the composition of the gradient, its timings, the column 
temperature, the flow-rate and the mobile phase compositions were optimized. At the end the influence of pH was studied, and this 
approach led to a clear resolution of the 26 amino acids. The method was validated by accuracy, precision, and recovery studies, by 
analyzing patient samples, and by comparing the quality control sample results with the classical ion-exchange method. 
INTRODUCTION 
Since the late 1980s the classical ion-exchange 
chromatographic method for the analysis of ami- 
no acids (AA) has been replaced by reversed- 
phase high-performance liquid chromatographic 
(HPLC) methods that are faster, more sensitive, 
and inexpensive. One of the two most widely used 
HPLC methods involves precolumn derivatiza- 
tion of the amino acids with phenyl isothiocya- 
nate (PITC). There are a fewreviews on AA anal- 
ysis by liquid chromatography [1,4]. The PITC 
method [3-141 is very common, owing to its early 
* Corresponding author. 
* Presented at the 43rd Annual National Meeting of the Amer- 
ican Clinical Chemistry Association, Washington, DC, July 
1991. Clin. Chew, 37 (1991) 986. 
commercial debut, its good sensitivity (picomo- 
lar), and the advantages of PITC over o-phthal- 
aldehyde. 
Recent years have seen an extensive commer- 
cialization of the analysis of AAs in physiological 
samples by various HPLC methods. In our view, 
this has contributed to a scarcity of the in-depth 
details necessary for a quick and successful adap- 
tation of these methods. Although there are pa- 
pers dealing with the PITC method [3-141, many 
workers have used the “Waters Pica Tag” system 
(consisting of their application-specific C1 s col- 
umn, dual pumps, mobile phases, gradient pro- 
gram, UV detector, work-station etc.) or at least 
the Waters column [5,6,8-lo]. Only a limited 
number of original systems [3,4,6,13,14] have 
been developed for the analysis of AAs in physio- 
logical samples using PITC, and all but one [6] 
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have only partially succeeded in separating all 25 an integrator plotter (Model D-2000, Hitachi). 
AAs. Few have described details of a successful All evaporations were done using a Speed Vat 
systematic approach to the development of a Concentrator (Model SVC lOOH, Savant, Hicks- 
method for the clear separation of all 25 AAs. ville, NY, USA). 
Our other objectives in the work were to (1) 
assemble an inexpensive, gradient HPLC-UV 
set-up that includes our own choice of analytical 
Cl* column, (2) develop a gradient that is simple 
in contrast to the more elaborate methods [3,5- 
8,101, (3) develop a method that includes as many 
of the common AAs as possible, (4) verify if the 
assay should be performed under ion-pairing 
conditions, as tried by many early workers [6,11], 
(5) validate the method by analyzing physiolog- 
ical samples, and determining accuracy and pre- 
cision data, and (6) reduce the analysis time per 
sample from 60 min or more [6,8-lo]. 
Chromatographic conditions 
The PITC-AA adducts were separated using a 
multistep linear gradient with two solvents. Sol- 
vent A was 0.050 M sodium acetate (pH 5.1)- 
acetonitrile (98:2, v/v). Solvent B was water-ace- 
tonitrile (40:60, v/v). Table I gives details of the 
linear gradient program (flow-rate 1.2 ml/min) 
used for the successful separation of the PITC 
derivatives. 
Standard solutions 
A single stock solution, containing 5 mM of all 
the 25 amino acids, was prepared in 1 mA4 hydro- 
chloric acid made using HPLC-grade water. This 
standard mixture was diluted to 20, 50, 100, 200, 
500,750 and 1000 PALM concentrations, aliquotted 
into micro-centrifuge tubes and kept at - 80°C. 
These standards are stable for ca. 1 year. Simi- 
larly, a working internal standard solution of 
norleucine of 40 @4 concentration was prepared, 
and 50 ~1 of the solution were added per 50 ~1 of 
ultrafiltrate prior to derivatization. 
EXPERIMENTAL 
Materials 
All amino acids, and the internal standard nor- 
leucine, were obtained from Sigma (St. Louis, 
MO, USA). Phenyl isothiocyanate was from Al- 
drich (Milwaukee, WI,USA). Triethylamine was 
from Mallinckrodt (Paris, KY, USA) and used 
without further purification. Sodium acetate and 
HPLC-grade acetonitrile were from J.T.Baker 
(Phillipsburg, NJ, USA). Reagent-grade water 
was obtained using a Milli-Q water system from 
Millipore (Bedford, MA, USA). The plasma ul- 
trafiltrate was obtained using the “Centrifree” 
micropartition system from Amicon (Beverly, 
MA, USA). 
Apparatus 
The HPLC system consisted of two pumps 
(Model M45, Waters, Bedford, MA, USA), a 
gradient controller (Model 680, Waters), a Cls 
“Econosphere” column (150 mm x 4.6 mm I.D., 
3 pm) from Alltech (Deerfield, IL, USA), a col- 
umn oven (Model LC-23A) with a temperature 
regulator (Model LC-22A) from Bioanalytical 
Systems (Lafayette, IN, USA), an autosampler 
“Wisp” Model 7lOB, Waters), a UV detector 
(Model 655A, Hitachi, Danbury, CT, USA) with 
a 5-mm path-length flow-cell set at 254 nm, and 
Samples 
Proper sample collection, processing, and stor- 
age are of utmost importance in this work be- 
cause the concentrations of many AAs are affect- 
ed by these factors [l]. Immediately after collec- 
TABLE I 
GRADIENT PROFILE FOR THE SEPARATION OF PITC- 
AA ADDUCT PEAKS 
Time (min) A (%) B(%) 
0 100 0 
29 52 48 
31 0 100 
43 0 100 
44 100 0 
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tion, the EDTA blood was spun at ca. 1500 g for 
15 min. A 500~~1 aliquot of separated plasma was 
pipetted into an Amicon Centrifree microparti- 
tion system and ultracentrifuged at 1500 g for 30 
min. The ultrafiltrate obtained was stored at 
- 80°C until analysis (cu. 1 month). 
Derivatization 
A 50-~1 volume of the ultrafiltrate (or the aque- 
ous standard) and 50 ~1 of the 40 ,L&! solution of 
the internal standard, norleucine, were pipetted 
into a micro-centrifuge tube, and the mixture was 
vacuum-dried using the Speed Vat concentrator. 
The procedure was repeated after adding and 
vortex-mixing with 10 ~1 of a solution of metha- 
nol-water-triethylamine (2: 1: 1, v/v). The AAs 
were derivatized using 20 ,ul of a solution of etha- 
nol, water, triethylamine, and PITC (7:l:l: 1, v/ 
v). The tubes were vortex-mixed and allowed to 
stand at room temperature for 10 min. The tubes 
were vacuum-dried using the Speed Vat Concen- 
trator. It took cu. 1 h to vacuum-dry 12 tubes. 
The residue was reconstituted in 500 ~1 of mobile 
phase A adjusted to pH 7.5, and 15 ~1 were in- 
jected into the HPLC system. 
Method development 
Cohen and Strydom successfully separated 25 
amino acids in ca. 60 min on a 3 ,um, reversed- 
phase Cl8 column (300 mm x 3.9 mm I.D.) 
[6,12] with a theoretical plate number of cu. 
22 000. We began our separation work by choos- 
ing the Econosphere Crs column (150 mm x 4.6 
mm I.D., 3 pm, Alltech, Deerfield, IL, USA) with 
a plate count of cu. 18 000, and a gradient system 
of two reagents. Reagent A was a 0.05 M ammo- 
nium acetate buffer of pH 6.8, and reagent B was 
water-acetonitrile (50:50, v/v). After a series of 
trials involving slight changes in mobile phase 
composition, flow-rate, and column temperature, 
and different gradient programs and timings, we 
tentatively optimized the chromatographic con- 
ditions. Mobile phase A was ammonium acetate 
(0.05 M, pH 6.8)-acetonitrile (98:2, v/v), and mo- 
bile phase B was water-acetonitrile (40:60, v/v). 
The flow-rate was 1.2 ml/mm, and the gradient 
program close to that in Table I. At this stage of 
the separation work, cu. 70% of the 26 PITC-AA 
adduct peaks were clearly resolved. The real chal- 
lenge of our work was reduced to the resolution 
of the following pairs of coeluting peaks at pH 
6.8: glycine and aspargine, tyrosine and valine, 
ornithine and tryptophan, and leucine and iso- 
leucine. 
Attempts were made to separate the above 
pairs of amino acids by studying the influence of 
one of the variables while keeping all others con- 
stant. Although many moderate changes were 
noted with the different variables, the influence of 
pH was most dramatic and was the key to the 
separation of all the four pairs of peaks. When 
the buffer pH value was close to 7.0, glycine and 
asparagine coeluted, with glycine following aspa- 
ragine. An increase in the temperature in this pH 
range only decreased the resolution of the two 
AAs. However, when the buffer pH was lowered 
to ea. 5.5, the order of elution reversed to aspara- 
gine first and glycine second. Further lowering of 
the pH below 5.5 increased the separation be- 
tween the two peaks. An increase in temperature 
further increased this separation at low pH. 
Changes in gradient timings did not have any sig- 
nificant effect on the resolution of the two peaks. 
When the buffer pH value was close to 5.2, the 
tyrosine and valine peaks were very clearly sep- 
arated. Temperature changes did not have any 
significant effect on the PITC-AA adduct peaks 
at lower pH values. Similar improved resolution 
was noted between tryptophan and ornithine at 
lower buffer pH values and without much tem- 
perature effect. The drawbacks of the lower pH 
value for the work was that the late-eluting re- 
agent peaks coeluted with leucine or isoleucine or 
the internal standard, norleucine. However, a 
slight change in the linear gradient timings 
moved the late-eluting reagent peaks sufficiently, 
and leucine and isoleucine eluted well before the 
reagent peak. Because a buffer of pH 5.1 better 
served the separation of the AAs, the mobile 
phase buffer was changed to a mixture of acetic 
acid and sodium acetate, and the column temper- 
ature was optimized to 41°C. 
At least two different groups [13,14] have stud- 
ied the influence of buffer nY on the resolution of 
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the peaks in this assay method. Both groups ini- 
tially studied the separation of the PITC-AA ad- 
duct peaks using a series of buffers in the pH 
range 5.0-7.6. They optimized the buffer pH 
while keeping constant all other variables, such 
as analytical column temperature, gradient pro- 
gram, mobile phase composition, and flow-rate. 
This optimized buffer did not provide complete 
separation of all the 25 peaks, and attempts were 
made by the two groups to improve the resolu- 
tion of the peaks by changing other variables. In 
contrast, we initially tried to resolve as many of 
the peaks by varying the gradient program, mo- 
bile phase composition, flow-rate, flow-cell di- 
mensions, and column temperature, and at the 
end we optimized the buffer pH. It seems that our 
approach was better in that we resolved 26 peaks 
in ea. 35 min, as compared with 17 or 20 peaks by 
the two groups. The pH (5.1) of our buffer is dif- 
ferent from almost all others [3-141 (pH 6.5-6.8) 
in this area of work, and this perhaps could part- 
ly be due to differences in the nature of the Cl8 
packing materials used. 
RESULTS AND DISCUSSION 
Fig. 1 is a chromatogram of a plasma pool ul- 
trafiltrate carried through the derivatization 
process. Fig. 2 shows a chromatogram of an un- 
derivatized protein-free filtrate at 254 nm, con- 
firming that there are no chromophores due to 
endogenous substances in the plasma ultrafiltrate 
at 254 nm. Table 11 gives the retention times of 
the PITC adducts with 35 different AAs. Table 
III gives details of the precision data for the 
method using a normal patient sample pool. The 
mean interassay coefficient of variation (C.V.) (n 
= 7) for PITC-AA adducts is 6.9%. The data 
compare quite well with literature reports 
[4,9,10]. The C.V. data for cystine and trypto- 
phan are somewhat higher because of their well- 
known instability [l]. Also, the low concentra- 
tions of aspartic acid, hydroxyproline, and tryp- 
tophan exaggerate their C.V. for the method. Ta- 
ble IV gives details of our recovery studies for 25 
amino acids (cystine omitted) by adding 20, 50, 
100, and 200 PLM of the standards to four differ- 




Fig. 1. HPLC separation of the PITC derivatives of 25 amino 
acids present in a human plasma after oral intake of “Aspar- 
tame”. Reagent peaks are marked by asterisks. 
0 5 10 15 20 25 30 
Fig. 2. Chromatogram of an underivatized protein-free ultra- 
filtrate of a normal human plasma (no absorption by endoge- 
nous compounds). 
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TABLE II 
RETENTION TIMES FOR THE PITC-AA ADDUCT 
PEAKS 
Amino acid Relative retention 
time, k’ 
We validated the method by analyzing plasma 
samples from liver disease patients on oral hyper- 
alimentation (Table V) to determine the absorp- 
tion rate as a function of time, and samples from 
patients who were orally given “Aspartame” (Ta- 
ble VI), an experiment useful in determining its 
effect on the transport of AAs across the blood- 
brain barrier [ 151. Aspartic acid (ASP) 1.79 
Hydroxyproline (HPRO) 2.14 
Glutamic acid (GLU) 2.45 
Serine (SER) 2.94 
Aspargine (ASN) 3.32 
Glycine (GLY) 3.56 
Glutamine (GLN) 4.14 
Hydroxyserine (HSER) 4.37 
Taurine (TAU) 4.51 
u-Aminoadipic acid (AAAA) 6.28 
Threonine (THR) 6.62 
B-Alanine (BALA) 6.71 
Citrulline (CIT) 6.96 
Alanine (ALA) 7.20 
Methioninesulphone (METS02) 7.61 
Histidine (HIS) 7.91 
Proline (PRO) 8.43 
D-Aminobutyric acid (BABA) 8.88 
I-Methylhistidine (I-MH) 9.39 
Arginine (ARG) 9.39 
F-Aminobutyric acid(GABA) 9.44 
Ethanolamine (EtOHNH2) 9.64 
c+Aminobutyric acid (AABA) 10.14 
Tyrosine (TYR) 12.44 
Valine (VAL) 13.22 
Methionine (MET) 13.47 
Cystine (CYS) 15.31 
Isoleucine (ILE) 16.45 
Leucine (LEU) 16.66 
Norleucine (NORLEU) 17.14 
Hydroxylysine (HYLYS) 17.27 
Phenylalaine (PHE) 17.79 
Ornithine (ORN) 18.15 
Tryptophan (TRP) 18.46 
Lysine (LYS) 19.59 
ent aliquots of the same normal pool that was 
earlier used as a quality control sample in the 
work. The average recovery of the amino acids 
was 99.9%. We found that the assay is linear up 
to 2 mmol. The detection limit of the assay is ca. 
1 pmol when the signal-to-noise ratio is 5:1, and 
any concerns about this claim [4] appear invalid. 
Some of the pioneering workers using the 
PITC method [6,1 l] have used ion-pairing condi- 
tions in the assay by adding triethylamine to the 
reagent A. The ion-pairing conditions sharpen 
many peaks, but many peaks coelute too [l 11. 
The retention times of PITC derivatives often 
change under these conditions [ 11, and our un- 
published results]. Without triethylamine, the re- 
tention times of peaks are highly reproducible for 
several assays, provided the column is in good 
condition. The main reasons for the poor repro- 
duciblity of the peak retention times under ion- 
pairing conditions are that the second and stron- 
II 11 I,11 “1 “1’ I ’ “1 1 ’ “1 I ““I’ 
0 5 10 15 20 25 30 
Time (min) 
Fig. 3. HPLC separation of PITC derivatives of a standard mix- 
ture of 25 AAs (50 mmol each) and norleucine (40 mmol). Re- 
agent peaks are marked by asterisks. 
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TABLE III 
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PRECISION DATA FOR THE PITC-AA ADDUCTS USING HUMAN PLASMA 
Amino acid Inter-assay 
Mean” (phf) C.V. (%) 
Intra-assay 
Mean“ (phf) C.V. (%) 
ASP 3.1 15.6 3.3 12.6 
HYPRO 1.3 13.2 7.1 1.4 
GLU 21.8 4.2 22.5 4.4 
SER 63.0 2.3 59.5 3.2 
ASN 43.8 4.6 44.5 2.9 
GLY 170.0 5.0 184.0 3.2 
GLN 608.0 1.6 592.1 2.3 
TAU 31.0 2.2 26.8 3.1 
THR 87.0 6.9 71.5 3.4 
CIT 71.0 4.0 66.3 3.2 
ALA 318.0 2.7 313.0 3.3 
HIS 75.0 2.4 78.5 2.5 
PRO 182.0 2.1 178.0 3.1 
ARG 78.0 2.6 84.0 2.4 
AABU 12.3 6.5 9.9 9.0 
TYR 50.0 3.3 47.3 4.1 
VAL 223.0 7.5 209.0 1.5 
MET 19.2 13.9 22.8 5.3 
CYS 108.0 14.4 90.0 5.0 
ILE 64.0 4.1 61.0 1.9 
LEU 123.0 2.8 119.0 1.7 
PHE 53.0 2.8 55.0 2.1 
ORN 50.3 3.5 58.0 3.1 
TRP 5.1 13.0 4.6 10.2 
LYS 113.0 8.2 102.0 1.3 
a n = 7. 
ger eluting mobile phase B washes out the ion- 
pairing reagent from the column, and that it 
takes longer to equilibrate the column with the 
solvent A. Even without the addition of triethyla- 
mine, the peaks are sharp and well resolved using 
a 5-mm path-length UV detector flow-cell and a 
much stronger eluting second mobile phase with 
60% acetonitrile. This is in contrast to Cohen 
and Strydom [6] who used a mobile phase B of 
water-acetonitrilmethanol (40:45: 15, v/v/v) to 
separate the PITC-AA adducts. 
It is possible that the indiscrete Cl8 column 
that we and Ebert [ 1 l] used is not completely end- 
capped, and the addition of triethylamine to the 
mobile phase produces a higher degree of interac- 
tion between the column and the eluting PITC- 
AA adducts (which in turn is associated with the 
ion-pairing agent). Such an interaction is perhaps 
minimal with the Waters’ amino acid Cl8 col- 
umn. In any case, care should be exercised in 
adding triethylamine to the mobile phases in this 
work. 
Table VII gives the mean concentrations of 
AAs (n = 5) by the HPLC method and the ion- 
exchange method for a normal plasma ultrafil- 
trate. The comparison is very good for many of 
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TABLE IV 
MEAN PERCENTAGE RECOVERY OF AMINO ACIDS 
USING SPIKED PLASMA (n = 5) 
TABLE V 
PLASMA AMINO ACIDS CONCENTRATIONS FOR A 
LIVER DISEASE PATIENT ON ORAL ALIMENTATION 
Values are in pM. 
Amino acid Spiked concentration (~Mf 
20 50 100 200 
ASP 92.3 92.9 90.9 87.6 
HYPRO 99.8 101.3 100.9 98.0 
GLU 94.8 93.2 91.4 89.1 
SER 104.0 100.4 93.3 89.6 
ASN 100.3 95.7 96.4 92.1 
GLY 113.4 107.3 97.3 89.5 
GLN 90.8 89.7 89.5 91.5 
TAU 104.8 99.9 97.6 93.5 
THR 95.4 94.3 94.1 87.1 
CIT 106.0 103.8 97.9 89.2 
ALA 105.0 100.0 88.8 88.9 
HIS 101.2 104.6 103.0 101.7 
PRO 100.4 86.3 95.1 93.6 
ARG 109.0 99.5 98.1 95.0 
TYR 101.3 101.9 99.9 97.9 
VAL 93.8 88.4 88.9 85.0 
MET 108.8 109.4 103.6 99.5 
CYS 114.1 119.2 120.7 112.4 
ILE 93.8 98.7 95.8 94.6 
LEU 102.0 103.5 100.7 99.4 
PHE 104.0 106.5 105.3 103.1 
ORN 112.3 111.9 105.5 104.5 
TRP 104.5 110.2 110.3 111.8 
LYS 124.2 113.4 118.7 115.8 
the amino acids, but poor for the following: gly- 
tine, proline, citruline, and methionine. The first 
two AAs are determined by an unconventional 
ratio in our ion-exchange method. The lower pre- 
cisions for citruline and methionine by the ion- 
exchange method are well known [4,5]. A similar 
poor precision for cystine, and the unstable na- 
ture of glutamine and asparagine, are character- 
istic of the PITC HPLC method. 
In conclusion, our work gives greater and 
unique details of a systematic approach to the 
developmental aspect of the AA analyses by the 
HPLC-UV method with precolumn derivatiza- 
Amino acid Time (min) 
0 90 180 240 
- 
ASP 6.4 12.3 15.2 13.0 
HPRO 19.1 29.6 28.7 29.6 
GLU 291 264 376 366 
SER 133 345 351 299 
ASN 68 209 191 160 
GLY 299 418 392 385 
GLN 374 853 833 781 
TAU 32 51 52 42 
THR 236 548 639 539 
ALA 194 653 541 208 
CIT 43 60 69 71 
HIS 69 132 127 I17 
PRO 446 917 935 846 
ARG 82 180 170 168 
TYR 185 314 339 341 
VAL 100 380 332 291 
MET 115 211 230 242 
CYS 9.6 9.6 19 14 
ILE 33 202 133 109 
LEU 59 313 199 146 
PHE 123 255 277 274 
TRP 29 38 79 65 
LYS 97 462 469 391 
ORN 92 144 198 203 
TABLE VI 
HUMAN PLASMA CONCENTRATIONS OF TYROSINE 
AND PHENYLALANINE FOR A PATIENT ORALLY GIV- 
EN “ASPARTAME” 
Sample TYR @CM) PHE (PM) 
1 37 42 
2 66 I63 
3 89 581 
4 94 449 
5 109 393 
6 107 309 
7 94 I92 
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TABLE VII 
COMPARISON OF AMINO ACID CONCENTRATIONS 
OF A NORMAL PLASMA OBTAINED BY THE PITC AND 
THE ION-EXCHANGE METHODS 
Values are in PM, n = 5. 




















































y Too small to be measured 8 
b Not measured. 9 
tion using PITC. The method is characterized by 
its simplicity, the use of an inexpensive and indis- 
crete Cl8 column, a simple gradient and a very 
short run-time, cu. 35 min per sample. We have 
validated the method with good precision, accu- 
racy, and recovery data, and by analyzing patient 
plasma samples. We have compared our HPLC 
results with the classical ion-exchange method. 
Our method is simple and can be readily adapted 
for any laboratory with the basic equipment and 
some chromatographic skills. 
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